Lithocholic acid
CAT:
804-HY-B0172-01
Size:
500 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Lithocholic acid
UNSPSC Description:
Lithocholic acid is a toxic secondary bile acid that can promote intrahepatic cholestasis and promote tumorigenesis. Lithocholic acid is also a FXR antagonist and a PXR/SXR agonist[1][2][3][4][5].Target Antigen:
Apoptosis; Autophagy; Endogenous Metabolite; FXRType:
Natural ProductsRelated Pathways:
Apoptosis;Autophagy;Metabolic Enzyme/ProteaseApplications:
Metabolism-sugar/lipid metabolismField of Research:
Cancer; Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/Lithocholic-acid.htmlPurity:
99.99Solubility:
DMSO : 250 mg/mL (ultrasonic)|Ethanol : 10 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 0.99 mg/mL (ultrasonic;warming;adjust pH to 11 with NaOH;heat to 60°C)Smiles:
C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(O)=O)([H])[C@@]3([H])[C@]([C@@]4([C@](C[C@H](O)CC4)([H])CC3)C)([H])CC1Molecular Weight:
376.57References & Citations:
[1]Jenkins, D.J., et al., Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med, 1993. 329(1): p. 21-6.|[2]Goldberg, A.A., et al., Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget, 2011. 2(10): p. 761-82.|[3]Matsubara, T., et al., TGF-beta-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury. J Lipid Res, 2012. 53(12): p. 2698-707.|[4]Yang R, et al. Metabolomic analysis of cholestatic liver damage in mice. Food Chem Toxicol. 2018 Jul 14;120:253-260.|[5]Yu J, et al. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem. 2002 Aug 30;277(35):31441-7.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Clinical Information:
Phase 3CAS Number:
434-13-9